DICP OpenIR

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling 期刊论文
ONCOTARGET, 2015, 卷号: 6, 期号: 13, 页码: 11627-11639
Authors:  Ding, Jin;  Wen, Wen;  Xiang, Daimin;  Yin, Peipei;  Liu, Yanfang;  Liu, Chang;  He, Guoping;  Cheng, Zhuo;  Yin, Jianpeng;  Sheng, Chunquan;  Zhang, Wen;  Nan, Fajun;  Ye, Wencai;  Zhang, Xiuli;  Wang, Hongyang
Favorite  |  View/Download:60/0  |  Submit date:2015/11/17
Psi-bufarenogin  Hepatocellular Carcinoma  Epithelial Growth Factor Receptor  Hepatocyte Growth Factor Receptor